Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Drug Alcohol Depend. 2014 Jun 2;141:107–117. doi: 10.1016/j.drugalcdep.2014.05.013

Fig. 4. Synergistic effect of mecamylamine and the nicotine-specific monoclonal antibody Nic311 for blocking the subjective effects of nicotine.

Fig. 4

Rats were trained in a two-lever nicotine discrimination assay. Data are the mean ± SE % responding on the nicotine lever during consecutive daily sessions with the 0.4 mg/kg s.c. nicotine training dose. Nic311 or control antibody was administered i.v. one day prior to session 1, and mecamylamine or saline was administered s.c. 15 minutes prior to each session. Dashed lines indicate criterion levels of performance for discrimination of the 0.4 mg/kg nicotine training dose. Significantly different from Control antibody+Saline, *p<0.05, ***p<0.001. Significantly different from Nic311+Saline, ##p<0.01, ###p<0.001. Reproduced from (LeSage et al., 2012).